This chemical is primarily used in the field of cancer research and therapy development. It functions as a targeted protein degrader, specifically designed to degrade MDM2, a protein that negatively regulates the tumor suppressor p53. By degrading MDM2, it helps restore p53 activity, which plays a crucial role in preventing cancer cell growth and inducing apoptosis (programmed cell death). This makes it a promising candidate for treating cancers where p53 is inactivated due to high levels of MDM2. Researchers utilize it to study the mechanisms of protein degradation and to develop novel therapeutic strategies for p53-dependent cancers. Its application is particularly relevant in preclinical studies aimed at understanding and combating tumor resistance mechanisms.